Keywords
Last Name
Institution

George Dangas

TitlePROFESSOR
InstitutionMount Sinai
DepartmentCardiology
Address196 03 42nd Avenue
Flushing NY 11361
Phone718-545-2250
    Other Positions
    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentSurgery


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Caixeta A, Généreux P, Palmerini T, Lansky AJ, Mehran R, Dangas GD, Xu K, Brener SJ, Stone GW. Prognostic Utility of the SYNTAX Score in Patients With Single Versus Multivessel Disease Undergoing Percutaneous Coronary Intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] Trial). Am J Cardiol. 2014 Jan 15; 113(2):203-10.
      View in: PubMed
    2. Palmerini T, Brener SJ, Mehran R, Dangas G, Genereux P, Riva DD, Mariani A, Xu K, Stone GW. Leukocyte count is a modulating factor for the mortality benefit of bivalirudin in ST-segment-elevation acute myocardial infarction: the HORIZONS-AMI trial. Circ Cardiovasc Interv. 2013 Oct 1; 6(5):518-26.
      View in: PubMed
    3. Dangas GD, Serruys PW, Kereiakes DJ, Hermiller J, Rizvi A, Newman W, Sudhir K, Smith RS, Cao S, Theodoropoulos K, Cutlip DE, Lansky AJ, Stone GW. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2013 Sep; 6(9):914-22.
      View in: PubMed
    4. Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ, Berger PB, Iakovou I, Dangas G, Waksman R, Antoniucci D, Sartori S, Krucoff MW, Hermiller JB, Shawl F, Gibson CM, Chieffo A, Alu M, Moliterno DJ, Colombo A, Pocock S. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet. 2013 Nov 23; 382(9906):1714-22.
      View in: PubMed
    5. Sanidas E, Dangas G. Evolution of intravascular assessment of coronary anatomy and physiology: from ultrasound imaging to optical and flow assessment. Eur J Clin Invest. 2013 Sep; 43(9):996-1008.
      View in: PubMed
    6. Kovacic JC, Limaye AM, Sartori S, Lee P, Patel R, Chandela S, Trost B, Roy S, Harari R, Narechania B, Karajgikar R, Kim MC, Krishnan P, Moreno P, Baber U, Mehran R, Dangas G, Kini AS, Sharma SK. Comparison of six risk scores in patients with triple vessel coronary artery disease undergoing PCI: Competing factors influence mortality, myocardial infarction, and target lesion revascularization. Catheter Cardiovasc Interv. 2013 Nov 15; 82(6):855-68.
      View in: PubMed
    7. Caixeta A, Lansky AJ, Mehran R, Brener SJ, Claessen B, Généreux P, Palmerini T, Witzenbichler B, Guagliumi G, Brodie BR, Dudek D, Fahy M, Dangas GD, Stone GW. Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial. EuroIntervention. 2013 Jun 22; 9(2):220-7.
      View in: PubMed
    8. Kini AS, Baber U, Kovacic JC, Limaye A, Ali ZA, Sweeny J, Maehara A, Mehran R, Dangas G, Mintz GS, Fuster V, Narula J, Sharma SK, Moreno PR. Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). J Am Coll Cardiol. 2013 Jul 2; 62(1):21-9.
      View in: PubMed
    9. Sergie Z, Lefèvre T, Van Belle E, Kakoulides S, Baber U, Deliargyris EN, Mehran R, Grube E, Reinöhl J, Dangas GD. Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies. J Thromb Thrombolysis. 2013 May; 35(4):483-93.
      View in: PubMed
    10. O'Neill B, Singh V, Kini A, Mehran R, Jacobs E, Knopf D, Alfonso CE, Martinez CA, Martinezclark P, O'Neill W, Heldman AW, Yu J, Baber U, Kovacic JC, Dangas G, Sharma S, Sartori S, Cohen MG. The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: A sub-analysis of the BRAVO study. Catheter Cardiovasc Interv. 2014 Jan 1; 83(1):148-53.
      View in: PubMed
    11. Nikolsky E, Mehran R, Yu J, Witzenbichler B, Brodie BR, Kornowski R, Brener S, Xu K, Dangas GD, Stone GW. Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial). Am J Cardiol. 2013 May 15; 111(10):1377-86.
      View in: PubMed
    12. Chen SL, Xu B, Han YL, Sheiban I, Zhang JJ, Ye F, Kwan TW, Paiboon C, Zhou YJ, Lv SZ, Dangas GD, Xu YW, Wen SY, Hong L, Zhang RY, Wang HC, Jiang TM, Wang Y, Chen F, Yuan ZY, Li WM, Leon MB. Comparison of double kissing crush versus Culotte stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective DKCRUSH-III study. J Am Coll Cardiol. 2013 Apr 9; 61(14):1482-8.
      View in: PubMed
    13. Hoebers LP, Claessen BE, Dangas GD, Park SJ, Colombo A, Moses JW, Henriques JP, Stone GW, Leon MB, Mehran R. Long-term clinical outcomes after percutaneous coronary intervention for chronic total occlusions in elderly patients (=75 years): five-year outcomes from a 1,791 patient multi-national registry. Catheter Cardiovasc Interv. 2013 Jul 1; 82(1):85-92.
      View in: PubMed
    14. Kikkert WJ, van Nes SH, Lieve KV, Dangas GD, van Straalen J, Vis M, Baan J, Koch KT, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP. Prognostic value of post-procedural aPTT in patients with ST-elevation myocardial infarction treated with primary PCI. Thromb Haemost. 2013 May; 109(5):961-70.
      View in: PubMed
    15. Claessen BE, Dangas GD, Godino C, Henriques JP, Leon MB, Park SJ, Stone GW, Moses JW, Colombo A, Mehran R. Impact of target vessel on long-term survival after percutaneous coronary intervention for chronic total occlusions. Catheter Cardiovasc Interv. 2013 Jul 1; 82(1):76-82.
      View in: PubMed
    16. Palmerini T, Généreux P, Mehran R, Dangas G, Caixeta A, Riva DD, Mariani A, Xu K, Stone GW. Association among leukocyte count, mortality, and bleeding in patients with non-ST-segment elevation acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial). Am J Cardiol. 2013 May 1; 111(9):1237-45.
      View in: PubMed
    17. Kikkert WJ, Claessen BE, Stone GW, Mehran R, Witzenbichler B, Brodie BR, Wöhrle J, Witkowski A, Guagliumi G, Zmudka K, Henriques JP, Tijssen JG, Sanidas EA, Chantziara V, Xu K, Dangas GD. Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudy. J Thromb Thrombolysis. 2013 Feb; 35(2):200-8.
      View in: PubMed
    18. Dangas GD, Claessen BE, Mehran R, Xu K, Stone GW. Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial. EuroIntervention. 2013 Jan 22; 8(9):1033-9.
      View in: PubMed
    19. Cubeddu RJ, Palacios IF, Blankenship JC, Horvath SA, Xu K, Kovacic JC, Dangas GD, Witzenbichler B, Guagliumi G, Kornowski R, Dudek D, Stone GW, Mehran R. Outcome of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention during on- versus off-hours (a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial substudy). Am J Cardiol. 2013 Apr 1; 111(7):946-54.
      View in: PubMed
    20. Yu J, Mehran R, Dangas GD, Claessen BE, Baber U, Xu K, Parise H, Fahy M, Lansky AJ, Witzenbichler B, Grines CL, Guagliumi G, Kornowski R, Wöhrle J, Dudek D, Weisz G, Stone GW. Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv. 2012 Dec; 5(12):1231-8.
      View in: PubMed
    21. Jarai R, Dangas G, Huber K, Xu K, Brodie BR, Witzenbichler B, Metzger DC, Radke PW, Yu J, Claessen BE, Genereux P, Mehran R, Stone GW. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial. Circ Cardiovasc Interv. 2012 Dec; 5(6):813-20.
      View in: PubMed
    22. Tamburino C, Capranzano P, Capodanno D, Dangas G, Zimarino M, Bass TA, Mehran R, Antoniucci D, Colombo A, La Manna A, Di Salvo ME, Stone GW. Percutaneous recanalization of chronic total occlusions: wherein lies the body of proof? Am Heart J. 2013 Feb; 165(2):133-42.
      View in: PubMed
    23. Hoebers LP, Vis MM, Claessen BE, van der Schaaf RJ, Kikkert WJ, Baan J, de Winter RJ, Piek JJ, Tijssen JG, Dangas GD, Henriques JP. The impact of multivessel disease with and without a co-existing chronic total occlusion on short- and long-term mortality in ST-elevation myocardial infarction patients with and without cardiogenic shock. Eur J Heart Fail. 2013 Apr; 15(4):425-32.
      View in: PubMed
    24. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S, Bertrand M, Fuster V. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012 Dec 20; 367(25):2375-84.
      View in: PubMed
    25. Saltzman AJ, Paz YE, Rene AG, Green P, Hassanin A, Argenziano MG, Rabbani L, Dangas G. Comparison of surgical pericardial drainage with percutaneous catheter drainage for pericardial effusion. J Invasive Cardiol. 2012 Nov; 24(11):590-3.
      View in: PubMed
    26. Dangas GD, Claessen BE, Mehran R, Xu K, Fahy M, Parise H, Henriques JP, Ohman EM, White HD, Stone GW. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. JACC Cardiovasc Interv. 2012 Nov; 5(11):1097-105.
      View in: PubMed
    27. Baber U, Dangas GD. Exercise physiology in the catheterization laboratory: still alive and well! Circulation. 2012 Nov 27; 126(22):2550-2.
      View in: PubMed
    28. Claessen BE, Chieffo A, Dangas GD, Godino C, Lee SW, Obunai K, Carlino M, Chantziara V, Apostolidou I, Henriques JP, Leon MB, Di Mario C, Park SJ, Stone GW, Moses JW, Colombo A, Mehran R. Gender differences in long-term clinical outcomes after percutaneous coronary intervention of chronic total occlusions. J Invasive Cardiol. 2012 Oct; 24(10):484-8.
      View in: PubMed
    29. Bansilal S, Farkouh ME, Hueb W, Ogdie M, Dangas G, Lansky AJ, Cohen DJ, Magnuson EA, Ramanathan K, Tanguay JF, Muratov V, Sleeper LA, Domanski M, Bertrand ME, Fuster V. The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry. Am Heart J. 2012 Oct; 164(4):591-9.
      View in: PubMed
    30. Dangas G, O'Connor D, Firwana B, Brar S, Ellozy S, Vouyouka A, Arnold M, Kosmas CE, Krishnan P, Wiley J, Suleman J, Olin J, Marin M, Faries P. Open versus endovascular stent graft repair of abdominal aortic aneurysms: a meta-analysis of randomized trials. JACC Cardiovasc Interv. 2012 Oct; 5(10):1071-80.
      View in: PubMed
    31. Claessen BE, Stone GW, Mehran R, Witzenbichler B, Brodie BR, Wöhrle J, Witkowski A, Guagliumi G, Zmudka K, Henriques JP, Tijssen JG, Sanidas EA, Chantziara V, Hakim D, Leon S, Xu K, Dangas GD. Relationship between biomarkers and subsequent clinical and angiographic restenosis after paclitaxel-eluting stents for treatment of STEMI: a HORIZONS-AMI substudy. J Thromb Thrombolysis. 2012 Aug; 34(2):165-79.
      View in: PubMed
    32. Capranzano P, Dangas G. Late stent thrombosis: the last remaining obstacle in coronary interventional therapy. Curr Cardiol Rep. 2012 Aug; 14(4):408-17.
      View in: PubMed
    33. Capodanno D, Dangas G. Facilitated/pharmaco-invasive approaches in STEMI. Curr Cardiol Rev. 2012 Aug; 8(3):177-80.
      View in: PubMed
    34. Singh HS, Dangas GD, Guagliumi G, Yu J, Witzenbichler B, Kornowski R, Grines C, Gersh B, Dudek D, Mehran R, Stone GW. Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial). Am J Cardiol. 2012 Oct 1; 110(7):940-7.
      View in: PubMed
    35. Dangas GD, Claessen BE, Mehran R, Brener S, Brodie BR, Dudek D, Witzenbichler B, Peruga JZ, Guagliumi G, Moses JW, Lansky AJ, Xu K, Stone GW. Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol. 2012 May 15; 59(20):1752-9.
      View in: PubMed
    36. Chirumamilla AP, Maehara A, Mintz GS, Mehran R, Kanwal S, Weisz G, Hassanin A, Hakim D, Guo N, Baber U, Pyo R, Moses JW, Fahy M, Kovacic JC, Dangas GD. High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study. JACC Cardiovasc Imaging. 2012 May; 5(5):540-9.
      View in: PubMed
    37. Rozenman Y, Mehran R, Witzenbichler B, Dangas G, Desaga M, Kochman J, Nilsen DW, Finkelstein A, Mosseri M, Stone GW. Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction. Catheter Cardiovasc Interv. 2013 Jan 1; 81(1):E9-14.
      View in: PubMed
    38. Palmerini T, Alessi L, Dangas G. Revascularization of unprotected left main coronary artery disease: strategy selection and systematic risk assessment. Catheter Cardiovasc Interv. 2012 Aug 1; 80(2):199-205.
      View in: PubMed
    39. Capranzano P, Dangas G. Bivalirudin for primary percutaneous coronary intervention in acute myocardial infarction: the HORIZONS-AMI trial. Expert Rev Cardiovasc Ther. 2012 Apr; 10(4):411-22.
      View in: PubMed
    40. Weintraub WS, Grau-Sepulveda MV, Weiss JM, O'Brien SM, Peterson ED, Kolm P, Zhang Z, Klein LW, Shaw RE, McKay C, Ritzenthaler LL, Popma JJ, Messenger JC, Shahian DM, Grover FL, Mayer JE, Shewan CM, Garratt KN, Moussa ID, Dangas GD, Edwards FH. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012 Apr 19; 366(16):1467-76.
      View in: PubMed
    41. Palmerini T, Caixeta A, Genereux P, Cristea E, Lansky A, Mehran R, Dangas G, Lazar D, Sanchez R, Fahy M, Xu K, Stone GW. Comparison of clinical and angiographic prognostic risk scores in patients with acute coronary syndromes: Analysis from the Acute Catheterization and Urgent Intervention Triage StrategY (ACUITY) trial. Am Heart J. 2012 Mar; 163(3):383-91, 391.e1-5.
      View in: PubMed
    42. Stone GW, Clayton TC, Mehran R, Dangas G, Parise H, Fahy M, Pocock SJ. Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial. Am Heart J. 2012 Mar; 163(3):522-9.
      View in: PubMed
    43. Baber U, Stone GW, Weisz G, Moreno P, Dangas G, Maehara A, Mintz GS, Cristea E, Fahy M, Xu K, Lansky AJ, Wennerblom B, Mathey DG, Templin B, Zhang Z, Serruys PW, Mehran R. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. JACC Cardiovasc Imaging. 2012 Mar; 5(3 Suppl):S53-61.
      View in: PubMed
    44. Weintraub WS, Grau-Sepulveda MV, Weiss JM, Delong ER, Peterson ED, O'Brien SM, Kolm P, Klein LW, Shaw RE, McKay C, Ritzenthaler LL, Popma JJ, Messenger JC, Shahian DM, Grover FL, Mayer JE, Garratt KN, Moussa ID, Edwards FH, Dangas GD. Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation. 2012 Mar 27; 125(12):1501-10.
      View in: PubMed
    45. Shahian DM, O'Brien SM, Sheng S, Grover FL, Mayer JE, Jacobs JP, Weiss JM, Delong ER, Peterson ED, Weintraub WS, Grau-Sepulveda MV, Klein LW, Shaw RE, Garratt KN, Moussa ID, Shewan CM, Dangas GD, Edwards FH. Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation. 2012 Mar 27; 125(12):1491-500.
      View in: PubMed
    46. Sergie Z, Dangas GD. In-stent restenosis of bifurcation lesions: experience with drug-eluting balloons. Catheter Cardiovasc Interv. 2012 Feb 15; 79(3):397-8.
      View in: PubMed
    47. Claessen BE, Dangas GD, Weisz G, Witzenbichler B, Guagliumi G, Möckel M, Brener SJ, Xu K, Henriques JP, Mehran R, Stone GW. Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. Eur Heart J. 2012 Mar; 33(6):768-75.
      View in: PubMed
    48. Palmerini T, Alessi L, Rizzo N, Dangas G. Percutaneous revascularization of left main: role of imaging, techniques, and adjunct pharmacology. Catheter Cardiovasc Interv. 2012 May 1; 79(6):990-9.
      View in: PubMed
    49. Nikolsky E, Mehran R, Dangas GD, Yu J, Parise H, Xu K, Pocock SJ, Stone GW. Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial). Am J Cardiol. 2012 Mar 15; 109(6):831-8.
      View in: PubMed
    50. Généreux P, Mehran R, Palmerini T, Caixeta A, Kirtane AJ, Lansky AJ, Brodie BR, Witzenbichler B, Mockel M, Guagliumi G, Peruga JZ, Dudek D, Fahy MP, Dangas G, Stone GW. Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial. EuroIntervention. 2011 Dec; 7(8):905-16.
      View in: PubMed
    51. Kovacic JC, Lee P, Baber U, Karajgikar R, Evrard SM, Moreno P, Mehran R, Fuster V, Dangas G, Sharma SK, Kini AS. Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions. Atherosclerosis. 2012 Mar; 221(1):176-82.
      View in: PubMed
    52. Kovacic JC, Mehran R, Karajgikar R, Baber U, Suleman J, Kim MC, Krishnan P, Dangas G, Sharma SK, Kini A. Female gender and mortality after percutaneous coronary intervention: results from a large registry. Catheter Cardiovasc Interv. 2012 Oct 1; 80(4):514-21.
      View in: PubMed
    53. Brar SS, ten Berg J, Marcucci R, Price MJ, Valgimigli M, Kim HS, Patti G, Breet NJ, DiSciascio G, Cuisset T, Dangas G. Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol. 2011 Nov 1; 58(19):1945-54.
      View in: PubMed
    54. Uretsky S, Rozanski A, Supariwala A, Khokhar S, Atluri P, Memon S, Dangas G, Fisher EA, Wolff SD, Robert Peters M. Physiological correlates of densely calcified coronary lesions on coronary computed tomography angiography among patients with low-to-intermediate coronary artery disease likelihood. Coron Artery Dis. 2011 Nov; 22(7):463-7.
      View in: PubMed
    55. Palmerini T, Dangas G, Mehran R, Caixeta A, Généreux P, Fahy MP, Xu K, Cristea E, Lansky AJ, Stone GW. Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial. Circ Cardiovasc Interv. 2011 Dec 1; 4(6):577-84.
      View in: PubMed
    56. Suh JW, Mehran R, Claessen BE, Xu K, Baber U, Dangas G, Parise H, Lansky AJ, Witzenbichler B, Grines CL, Guagliumi G, Kornowski R, Wöhrle J, Dudek D, Weisz G, Stone GW. Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol. 2011 Oct 18; 58(17):1750-6.
      View in: PubMed
    57. Kelly DJ, Gershlick T, Witzenbichler B, Guagliumi G, Fahy M, Dangas G, Mehran R, Stone GW. Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. Am Heart J. 2011 Oct; 162(4):663-70.
      View in: PubMed
    58. Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, Kim HS, Park SJ, Kastrati A, de Waha A, Krishnan P, Moreno P, Sweeny J, Kim MC, Suleman J, Pyo R, Wiley J, Kovacic J, Kini AS, Dangas GD. Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. J Am Coll Cardiol. 2011 Oct 4; 58(15):1569-77.
      View in: PubMed
    59. Spargias K, Polymeros S, Dimopoulos A, Manginas A, Pavlides G, Balanika M, Smirli A, Stavridis G, Dangas G, Cokkinos DV. The predictive value and evolution of N-terminal pro-B-type natriuretic peptide levels following transcutaneous aortic valve implantation. J Interv Cardiol. 2011 Oct; 24(5):462-9.
      View in: PubMed
    60. Saltzman AJ, Stone GW, Claessen BE, Narula A, Leon-Reyes S, Weisz G, Brodie B, Witzenbichler B, Guagliumi G, Kornowski R, Dudek D, Metzger DC, Lansky AJ, Nikolsky E, Dangas GD, Mehran R. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv. 2011 Sep; 4(9):1011-9.
      View in: PubMed
    61. Mehran R, Claessen BE, Godino C, Dangas GD, Obunai K, Kanwal S, Carlino M, Henriques JP, Di Mario C, Kim YH, Park SJ, Stone GW, Leon MB, Moses JW, Colombo A. Long-term outcome of percutaneous coronary intervention for chronic total occlusions. JACC Cardiovasc Interv. 2011 Sep; 4(9):952-61.
      View in: PubMed
    62. Claessen BE, Mehran R, Mintz GS, Weisz G, Leon MB, Dogan O, de Ribamar Costa J, Stone GW, Apostolidou I, Morales A, Chantziara V, Syros G, Sanidas E, Xu K, Tijssen JG, Henriques JP, Piek JJ, Moses JW, Maehara A, Dangas GD. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. JACC Cardiovasc Interv. 2011 Sep; 4(9):974-81.
      View in: PubMed
    63. Goto K, Nikolsky E, Lansky AJ, Dangas G, Witzenbichler B, Parise H, Guagliumi G, Kornowski R, Claessen BE, Fahy M, Mehran R, Stone GW. Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial). Am J Cardiol. 2011 Nov 15; 108(10):1387-94.
      View in: PubMed
    64. Kornowski R, Mehran R, Dangas G, Nikolsky E, Assali A, Claessen BE, Gersh BJ, Wong SC, Witzenbichler B, Guagliumi G, Dudek D, Fahy M, Lansky AJ, Stone GW. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol. 2011 Aug 9; 58(7):704-11.
      View in: PubMed
    65. Claessen BE, Dangas GD, Godino C, Lee SW, Obunai K, Carlino M, Suh JW, Leon MB, Di Mario C, Park SJ, Stone GW, Moses JW, Colombo A, Mehran R. Long-term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus. Am J Cardiol. 2011 Oct 1; 108(7):924-31.
      View in: PubMed
    66. Dangas GD, Sanidas EA, Castellanos C. Endovascular treatment of infrarenal aortic stenosis: importance of multimodality imaging. J Invasive Cardiol. 2011 Aug; 23(8):E192-6.
      View in: PubMed
    67. Baber U, Kovacic J, Kini AS, Sharma SK, Dangas G, Mehran R. How serious a problem is bleeding in patients with acute coronary syndromes? Curr Cardiol Rep. 2011 Aug; 13(4):312-9.
      View in: PubMed
    68. Yu J, Dangas G. Commentary: New insights into the risk factors of contrast-induced encephalopathy. J Endovasc Ther. 2011 Aug; 18(4):545-6.
      View in: PubMed
    69. George JC, Varghese V, Dangas G, Feldman TE. Percutaneous mitral valve repair: lessons from the EVEREST II (Endovascular Valve Edge-to-Edge REpair Study) and beyond. JACC Cardiovasc Interv. 2011 Jul; 4(7):825-7.
      View in: PubMed
    70. Stone GW, Vora K, Schindler J, Diaz C, Mann T, Dangas G, Best P, Cutlip DE. Systemic hypothermia to prevent radiocontrast nephropathy (from the COOL-RCN Randomized Trial). Am J Cardiol. 2011 Sep 1; 108(5):741-6.
      View in: PubMed
    71. Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Dangas G, Lazar D, Sanchez R, Fahy M, Xu K, Stone GW. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol. 2011 Jun 14; 57(24):2389-97.
      View in: PubMed
    72. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Fahy M, Parise H, Mehran R. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet. 2011 Jun 25; 377(9784):2193-204.
      View in: PubMed
    73. Dangas GD, Mehran R, Nikolsky E, Claessen BE, Lansky AJ, Brodie BR, Witzenbichler B, Guagliumi G, Peruga JZ, Dudek D, Möckel M, Caixeta A, Parise H, White H, Stone GW. Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis. J Am Coll Cardiol. 2011 Jun 7; 57(23):2309-16.
      View in: PubMed
    74. Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, Caixeta A, Feit F, Manoukian SV, White H, Bertrand M, Ohman EM, Parise H, Lansky AJ, Lincoff AM, Stone GW. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv. 2011 Jun; 4(6):654-64.
      View in: PubMed
    75. Claessen BE, Dangas GD. Thrombus aspiration in primary percutaneous coronary intervention how to manage failure. JACC Cardiovasc Interv. 2011 Jun; 4(6):643-4.
      View in: PubMed
    76. Dangas G. To excel or to confirm? That is the question. Catheter Cardiovasc Interv. 2011 Jun 1; 77(7):944.
      View in: PubMed
    77. Palmerini T, Mehran R, Dangas G, Nikolsky E, Witzenbichler B, Guagliumi G, Dudek D, Genereux P, Caixeta A, Rabbani L, Weisz G, Parise H, Fahy M, Xu K, Brodie B, Lansky A, Stone GW. Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial. Circulation. 2011 Jun 21; 123(24):2829-37, 7 p following 2837.
      View in: PubMed
    78. Sanz J, Dangas GD. [Dynamic nature of coronary plaques and clinical outcomes in diabetic patients: is change in itself bad?]. Rev Esp Cardiol. 2011 Jul; 64(7):549-50.
      View in: PubMed
    79. Choi SY, Witzenbichler B, Maehara A, Lansky AJ, Guagliumi G, Brodie B, Kellett MA, Dressler O, Parise H, Mehran R, Dangas GD, Mintz GS, Stone GW. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy. Circ Cardiovasc Interv. 2011 Jun; 4(3):239-47.
      View in: PubMed
    80. Iakovou I, Dimopoulos A, Dangas G. Normal to normal: a method of treatment of coronary aneurysms with deployment of bare-metal stents. J Invasive Cardiol. 2011 May; 23(5):E121-5.
      View in: PubMed
    81. Dangas GD, Caixeta A, Mehran R, Parise H, Lansky AJ, Cristea E, Brodie BR, Witzenbichler B, Guagliumi G, Peruga JZ, Dudek D, Möeckel M, Stone GW. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation. 2011 Apr 26; 123(16):1745-56.
      View in: PubMed
    82. Hahalis G, Dangas G, Davlouros P, Alexopoulos D. Revascularization strategies for stable multivessel and unprotected left main coronary artery disease: from BARI to SYNTAX. Int J Cardiol. 2011 Dec 1; 153(2):126-34.
      View in: PubMed
    83. Sanidas EA, Maehara A, Mintz GS, Kashiyama T, Guo J, Pu J, Shang Y, Claessen B, Dangas GD, Leon MB, Moses JW, Stone GW, Ueda Y. Angioscopic and virtual histology intravascular ultrasound characteristics of culprit lesion morphology underlying coronary artery thrombosis. Am J Cardiol. 2011 May 1; 107(9):1285-90.
      View in: PubMed
    84. Stone GW, Goldberg S, O'Shaughnessy C, Midei M, Siegel RM, Cristea E, Dangas G, Lansky AJ, Mehran R. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial. JACC Cardiovasc Interv. 2011 Mar; 4(3):300-9.
      View in: PubMed
    85. Hakim DA, Dangas GD, Caixeta A, Nikolsky E, Lansky AJ, Moses JW, Claessen B, Sanidas E, White HD, Ohman EM, Manoukian SV, Fahy M, Mehran R, Stone GW. Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Am Heart J. 2011 Feb; 161(2):391-6.
      View in: PubMed
    86. Caixeta A, Stone GW, Mehran R, Lee EA, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Ohman EM, Palmerini T, Syros G, Kittas C, Fahy M, Hooper WC, Lansky AJ, Dangas GD. Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial. J Thromb Thrombolysis. 2011 Feb; 31(2):154-64.
      View in: PubMed
    87. Caixeta A, Dangas GD, Mehran R, Feit F, Nikolsky E, Lansky AJ, Aoki J, Moses JW, Steinhubl SR, White HD, Ohman EM, Manoukian SV, Fahy M, Stone GW. Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Am Heart J. 2011 Feb; 161(2):298-306.e1.
      View in: PubMed
    88. Campbell CL, Steinhubl SR, Hooper WC, Jozic J, Smyth SS, Bernstein D, De Staercke C, Syros G, Negus BH, Stuckey T, Stone GW, Mehran R, Dangas G. Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy. J Thromb Thrombolysis. 2011 Feb; 31(2):139-45.
      View in: PubMed
    89. Capodanno D, Tamburino C, Dangas G. The optimal pharmacological formula for percutaneous coronary intervention. Expert Opin Pharmacother. 2011 May; 12(7):1075-86.
      View in: PubMed
    90. Magallon J, Chen J, Rabbani L, Dangas G, Yang J, Bussel J, Diacovo T. Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents. Circulation. 2011 Jan 25; 123(3):319-26.
      View in: PubMed
    91. George JC, Varghese V, Dangas G, Popma JJ. Transcatheter aortic valve implantation: lessons from the PARTNER (Placement of Aortic Transcatheter Valves) trial. JACC Cardiovasc Interv. 2011 Jan; 4(1):132-3.
      View in: PubMed
    92. Claessen BE, Mehran R, Leon MB, Heller EA, Weisz G, Syros G, Mintz GS, Franklin-Bond T, Apostolidou I, Henriques JP, Stone GW, Moses JW, Dangas GD. Two-year safety and effectiveness of sirolimus-eluting stents (from a prospective registry). Am J Cardiol. 2011 Feb 15; 107(4):528-34.
      View in: PubMed
    93. Dangas G, Erwin P. Angiographic complications and post-PCI myocardial enzyme elevation: brave new world revisited. Catheter Cardiovasc Interv. 2010 Dec 1; 76(7):967-8.
      View in: PubMed
    94. Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010 Nov 30; 56(23):1897-907.
      View in: PubMed
    95. Capranzano P, Mehran R, Tamburino C, Stone GW, Dangas G. Clinical impact of enhanced inhibition of P2Y12-mediated platelet aggregation in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Hosp Pract (1995). 2010 Nov; 38(4):38-43.
      View in: PubMed
    96. Dangas GD, Sharma SK, Mehran R. Acute myocardial infarction and multivessel disease: some vessels are more equal than others. Heart. 2010 Dec; 96(24):1955-6.
      View in: PubMed
    97. Dangas GD, George JC, Weintraub W, Popma JJ. Timing of staged percutaneous coronary intervention in multivessel coronary artery disease. JACC Cardiovasc Interv. 2010 Oct; 3(10):1096-9.
      View in: PubMed
    98. Genereux P, Dangas G. Antegrade, retrograde, and combination strategies for chronic total occlusions. Curr Cardiol Rep. 2010 Sep; 12(5):429-39.
      View in: PubMed
    99. Kumar D, Dangas G, Mehran R, Kirtane A, Bertrand M, Ebrahimi R, Guagliumi G, Brar S, Fahy M, Heller E, Moses J, Stone G. Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary grafts (the ACUITY trial investigators). Am J Cardiol. 2010 Oct 1; 106(7):941-5.
      View in: PubMed
    100. Claessen BE, Henriques JP, George JC, Dangas GD. Society for Cardiovascular Angiography and Interventions 2010 and EuroPCR 2010: an update in interventional cardiology. JACC Cardiovasc Interv. 2010 Aug; 3(8):882-4.
      View in: PubMed
    101. Mavrogeni S, Papavasiliou A, Skouteli E, Magoutas A, Dangas G. Cardiovascular magnetic resonance imaging evaluation of two families with Becker muscular dystrophy. Neuromuscul Disord. 2010 Nov; 20(11):717-9.
      View in: PubMed
    102. Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, Parise H, Fahy M, Manoukian SV, Feit F, Ohman ME, Witzenbichler B, Guagliumi G, Lansky AJ, Stone GW. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010 Jun 8; 55(23):2556-66.
      View in: PubMed
    103. Dangas GD, Singh HS. Primary percutaneous coronary intervention in octogenarians: navigate with caution. Heart. 2010 Jun; 96(11):813-4.
      View in: PubMed
    104. Mehran R, Brar S, Dangas G. Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality? J Am Coll Cardiol. 2010 May 18; 55(20):2210-1.
      View in: PubMed
    105. George JC, Moliterno DJ, Dangas GD. American College of Cardiology Annual Scientific Session 2010: update in interventional cardiology. JACC Cardiovasc Interv. 2010 May; 3(5):562-4.
      View in: PubMed
    106. Tsujita K, Nikolsky E, Lansky AJ, Dangas G, Fahy M, Brodie BR, Dudek D, Möckel M, Ochala A, Mehran R, Stone GW. Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). Am J Cardiol. 2010 May 15; 105(10):1385-94.
      View in: PubMed
    107. Ben-Gal Y, Weisz G, Collins MB, Genereux P, Dangas GD, Teirstein PS, Singh VP, Rabbani LE, Kodali SK, Sherman W, Leon MB, Moses JW. Dual catheter technique for the treatment of severe coronary artery perforations. Catheter Cardiovasc Interv. 2010 Apr 1; 75(5):708-12.
      View in: PubMed
    108. George JC, Dangas GD. Maintenance of certification in interventional cardiology revisited. JACC Cardiovasc Interv. 2010 Apr; 3(4):461-2.
      View in: PubMed
    109. Oviedo C, Maehara A, Mintz GS, Araki H, Choi SY, Tsujita K, Kubo T, Doi H, Templin B, Lansky AJ, Dangas G, Leon MB, Mehran R, Tahk SJ, Stone GW, Ochiai M, Moses JW. Intravascular ultrasound classification of plaque distribution in left main coronary artery bifurcations: where is the plaque really located? Circ Cardiovasc Interv. 2010 Apr; 3(2):105-12.
      View in: PubMed
    110. Dib N, Menasche P, Bartunek JJ, Zeiher AM, Terzic A, Chronos NA, Henry TD, Peters NS, Fernández-Avilés F, Yacoub M, Sanborn TA, Demaria A, Schatz RA, Taylor DA, Fuchs S, Itescu S, Miller LW, Dinsmore JH, Dangas GD, Popma JJ, Hall JL, Holmes DR. Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. JACC Cardiovasc Interv. 2010 Mar; 3(3):265-75.
      View in: PubMed
    111. Oviedo C, Maehara A, Mintz GS, Tsujita K, Kubo T, Doi H, Castellanos C, Lansky AJ, Mehran R, Dangas G, Leon MB, Stone GW, Templin B, Araki H, Ochiai M, Moses JW. Is accurate intravascular ultrasound evaluation of the left circumflex ostium from a left anterior descending to left main pullback possible? Am J Cardiol. 2010 Apr 1; 105(7):948-54.
      View in: PubMed
    112. George JC, Dangas GD. 2009 Focused updates to guidelines in ST-elevation myocardial infarction and percutaneous coronary intervention: application to interventional cardiology. JACC Cardiovasc Interv. 2010 Feb; 3(2):256-8.
      View in: PubMed
    113. Saltzman AJ, Mehran R, Hooper WC, Moses JW, Weisz G, Collins MB, Lansky AJ, Kreps EM, Leon MB, Stone GW, Dangas G. The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention. J Invasive Cardiol. 2010 Jan; 22(1):2-6.
      View in: PubMed
    114. Saltzman AJ, Mehran R, Dangas GD. Safety issues related to treating bifurcation lesions. Rev Cardiovasc Med. 2010; 11 Suppl 1:S3-10.
      View in: PubMed
    115. Klein LW, Edwards FH, DeLong ER, Ritzenthaler L, Dangas GD, Weintraub WS. ASCERT: the American College of Cardiology Foundation--the Society of Thoracic Surgeons Collaboration on the comparative effectiveness of revascularization strategies. JACC Cardiovasc Interv. 2010 Jan; 3(1):124-6.
      View in: PubMed
    116. Claessen BE, Henriques JP, Dangas GD. Clinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systems. Curr Pharm Des. 2010; 16(36):4012-24.
      View in: PubMed
    117. George JC, Dangas GD. European Society of Cardiology Congress 2009 update in interventional cardiology. JACC Cardiovasc Interv. 2009 Nov; 2(11):1160-2.
      View in: PubMed
    118. Kandzari DE, Colombo A, Park SJ, Tommaso CL, Ellis SG, Guzman LA, Teirstein PS, Tamburino C, Ormiston J, Stone GW, Dangas GD, Popma JJ, Bass TA. Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards. J Am Coll Cardiol. 2009 Oct 20; 54(17):1576-88.
      View in: PubMed
    119. Dangas G, Mehran R, Guagliumi G, Caixeta A, Witzenbichler B, Aoki J, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Rabbani LE, Parise H, Stone GW. Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol. 2009 Oct 6; 54(15):1438-46.
      View in: PubMed
    120. Liu X, Tsujita K, Maehara A, Mintz GS, Weisz G, Dangas GD, Lansky AJ, Kreps EM, Rabbani LE, Collins M, Stone GW, Moses JW, Mehran R, Leon MB. Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation. JACC Cardiovasc Interv. 2009 Oct; 2(10):997-1004.
      View in: PubMed
    121. Nikolsky E, Stone GW, Kirtane AJ, Dangas GD, Lansky AJ, McLaurin B, Lincoff AM, Feit F, Moses JW, Fahy M, Manoukian SV, White HD, Ohman EM, Bertrand ME, Cox DA, Mehran R. Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol. 2009 Sep 29; 54(14):1293-302.
      View in: PubMed
    122. Brar SS, Gray WA, Dangas G, Leon MB, Aharonian VJ, Brar SK, Moses JW. Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials. EuroIntervention. 2009 Sep; 5(4):475-84.
      View in: PubMed
    123. Mehran R, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Wong SC, Nikolsky E, Gambone L, Vandertie L, Parise H, Dangas GD, Stone GW. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet. 2009 Oct 3; 374(9696):1149-59.
      View in: PubMed
    124. Brar SS, Hiremath S, Dangas G, Mehran R, Brar SK, Leon MB. Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009 Oct; 4(10):1584-92.
      View in: PubMed
    125. Mehran R, Nikolsky E, Lansky AJ, Kirtane AJ, Kim YH, Feit F, Manoukian S, Moses JW, Ebrahimi R, Ohman EM, White HD, Pocock SJ, Dangas GD, Stone GW. Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy. JACC Cardiovasc Interv. 2009 Aug; 2(8):748-57.
      View in: PubMed
    126. Dangas G. Clinical investigation in ACS and PCI: shooting in the dark at a moving target. Catheter Cardiovasc Interv. 2009 Aug 1; 74(2):365-6.
      View in: PubMed
    127. Rabbani LE, Iyengar S, Dangas GD, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Stant J, Fahy M, Lansky AJ, Mehran R, Stone GW. Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction. J Interv Cardiol. 2009 Aug; 22(4):378-84.
      View in: PubMed
    128. Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Ochala A, Kellock A, Parise H, Mehran R. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009 May 7; 360(19):1946-59.
      View in: PubMed
    129. Brar SS, Leon MB, Stone GW, Mehran R, Moses JW, Brar SK, Dangas G. Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol. 2009 May 5; 53(18):1677-89.
      View in: PubMed
    130. Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Kim YH, Fahy M, Dangas GD. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. JACC Cardiovasc Interv. 2009 May; 2(5):415-21.
      View in: PubMed
    131. Liu X, Doi H, Maehara A, Mintz GS, Costa Jde R, Sano K, Weisz G, Dangas GD, Lansky AJ, Kreps EM, Collins M, Fahy M, Stone GW, Moses JW, Leon MB, Mehran R. A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. JACC Cardiovasc Interv. 2009 May; 2(5):428-34.
      View in: PubMed
    132. Dangas GD, Popma JJ. JACC White Papers: an avenue for interventional knowledge? JACC Cardiovasc Interv. 2009 May; 2(5):472-3.
      View in: PubMed
    133. Moussa ID, Jaff MR, Mehran R, Gray W, Dangas G, Lazic Z, Moses JW. Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: the Peripheral Arterial Disease in Interventional Patients Study. Catheter Cardiovasc Interv. 2009 May 1; 73(6):719-24.
      View in: PubMed
    134. Mehran R, Pocock SJ, Stone GW, Clayton TC, Dangas GD, Feit F, Manoukian SV, Nikolsky E, Lansky AJ, Kirtane A, White HD, Colombo A, Ware JH, Moses JW, Ohman EM. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. Eur Heart J. 2009 Jun; 30(12):1457-66.
      View in: PubMed
    135. Tsujita K, Maehara A, Mintz GS, Doi H, Kubo T, Castellanos C, Liu J, Yang J, Oviedo C, Franklin-Bond T, Sugirtharaj DD, Dangas GD, Lansky AJ, Stone GW, Moses JW, Leon MB, Mehran R. Impact of myocardial bridge on clinical outcome after coronary stent placement. Am J Cardiol. 2009 May 15; 103(10):1344-8.
      View in: PubMed
    136. Doi H, Maehara A, Mintz GS, Tsujita K, Kubo T, Castellanos C, Liu J, Yang J, Oviedo C, Aoki J, Franklin-Bond T, Dasgupta N, Lansky AJ, Dangas GD, Stone GW, Moses JW, Mehran R, Leon MB. Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. Am J Cardiol. 2009 Mar 15; 103(6):818-23.
      View in: PubMed
    137. Tamburino C, La Manna A, Di Salvo ME, Sacchetta G, Capodanno D, Mehran R, Dangas G, Corcos T, Prati F. First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial. JACC Cardiovasc Interv. 2009 Mar; 2(3):197-204.
      View in: PubMed
    138. Tamburino C, Di Salvo ME, Capodanno D, Capranzano P, Parisi R, Mirabella F, Scardaci F, Ussia G, Galassi AR, Fiscella D, Mehran R, Dangas G. Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting STent (TEST) registry. Catheter Cardiovasc Interv. 2009 Feb 1; 73(2):243-8.
      View in: PubMed
    139. Syros G, Mehran R, Weisz G, Kittas C, Moses JW, Leon M, Dangas G. Role of PLA2 polymorphism on clinical events after percutaneous coronary intervention. Acute Card Care. 2009; 11(2):88-91.
      View in: PubMed
    140. Moses JW, Dangas G, Mehran R, Mintz GS. Drug-eluting stents in the real world: how intravascular ultrasound can improve clinical outcome. Am J Cardiol. 2008 Nov 3; 102(9 Suppl):24J-8J.
      View in: PubMed
    141. Sanidas EA, Vavuranakis M, Papaioannou TG, Kakadiaris IA, Carlier S, Syros G, Dangas G, Stefanadis C. Study of atheromatous plaque using intravascular ultrasound. Hellenic J Cardiol. 2008 Nov-Dec; 49(6):415-21.
      View in: PubMed
    142. Tsujita K, Maehara A, Mintz GS, Doi H, Kubo T, Castellanos C, Liu J, Yang J, Oviedo C, Franklin-Bond T, Dasgupta N, Biro S, Dani L, Dangas GD, Mehran R, Kirtane AJ, Lansky AJ, Kreps EM, Collins MB, Stone GW, Moses JW, Leon MB. Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery. Am J Cardiol. 2008 Dec 15; 102(12):1608-13.
      View in: PubMed
    143. Popma JJ, Dangas GD, Tommaso CL, Bailes SC. Structure and function of the ACC Interventional Scientific Council and Section. JACC Cardiovasc Interv. 2008 Aug; 1(4):452-5.
      View in: PubMed
    144. Mehran R, Brodie B, Cox DA, Grines CL, Rutherford B, Bhatt DL, Dangas G, Feit F, Ohman EM, Parise H, Fahy M, Lansky AJ, Stone GW. The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. Am Heart J. 2008 Jul; 156(1):44-56.
      View in: PubMed
    145. Brar SS, Syros G, Dangas G. Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications. Angiology. 2008 Apr-May; 59(2 Suppl):83S-8S.
      View in: PubMed
    146. Dangas GD, Popma JJ. Recertification in interventional cardiology. JACC Cardiovasc Interv. 2008 Jun; 1(3):332-4.
      View in: PubMed
    147. Mehran R, Dangas GD. Revascularization of a chronically occluded left anterior descending artery: is it worth all the effort? JACC Cardiovasc Interv. 2008 Jun; 1(3):303-4.
      View in: PubMed
    148. Nikolsky E, Holmes DR, Mehran R, Dangas G, Schampaert E, Morice MC, Schofer J, Sousa JE, Fahy M, Na Y, Donohoe DJ, Moses JW, Leon MB. Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents. Catheter Cardiovasc Interv. 2008 Jun 1; 71(7):896-906.
      View in: PubMed
    149. Solinas E, Dangas G, Kirtane AJ, Lansky AJ, Franklin-Bond T, Boland P, Syros G, Kim YH, Gupta A, Mintz G, Fahy M, Collins M, Kodali S, Stone GW, Moses JW, Leon MB, Mehran R. Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. Am J Cardiol. 2008 Aug 1; 102(3):311-5.
      View in: PubMed
    150. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008 May 22; 358(21):2218-30.
      View in: PubMed
    151. Farkouh ME, Dangas G, Leon MB, Smith C, Nesto R, Buse JB, Cohen DJ, Mahoney E, Sleeper L, King S, Domanski M, McKinlay S, Fuster V. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J. 2008 Feb; 155(2):215-23.
      View in: PubMed
    152. Aoki J, Kirtane A, Leon MB, Dangas G. Coronary artery aneurysms after drug-eluting stent implantation. JACC Cardiovasc Interv. 2008 Feb; 1(1):14-21.
      View in: PubMed
    153. Caixeta A, Abizaid A, Aoki J, Dangas G, Mehran R. Future stent drug delivery systems. Minerva Cardioangiol. 2008 Feb; 56(1):155-66.
      View in: PubMed
    154. Dangas G, Stone GW, Weinberg MD, Webb J, Cox DA, Brodie BR, Krucoff MW, Gibbons RJ, Lansky AJ, Mehran R. Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial). Am Heart J. 2008 Jun; 155(6):1090-6.
      View in: PubMed
    155. Kim YH, Dangas GD, Solinas E, Aoki J, Parise H, Kimura M, Franklin-Bond T, Dasgupta NK, Kirtane AJ, Moussa I, Lansky AJ, Collins M, Stone GW, Leon MB, Moses JW, Mehran R. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. Am J Cardiol. 2008 Mar 15; 101(6):801-6.
      View in: PubMed
    156. Pucelikova T, Dangas G, Mehran R. Contrast-induced nephropathy. Catheter Cardiovasc Interv. 2008 Jan 1; 71(1):62-72.
      View in: PubMed
    157. Pocock SJ, Lansky AJ, Mehran R, Popma JJ, Fahy MP, Na Y, Dangas G, Moses JW, Pucelikova T, Kandzari DE, Ellis SG, Leon MB, Stone GW. Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol. 2008 Jan 1; 51(1):23-32.
      View in: PubMed
    158. Missel E, Mintz GS, Carlier SG, Sano K, Qian J, Kaple RK, Castellanos C, Dangas G, Mehran R, Moses JW, Stone GW, Leon MB. Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome. Am J Cardiol. 2008 Mar 1; 101(5):573-8.
      View in: PubMed
    159. Solinas E, Gobbi G, Dangas G, Mehran R, Fahy M, Ippolito L, Bolognesi MG, Ruenes R, Merlini PA, Ardissino D, Vitale M. Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes. J Thromb Thrombolysis. 2009 Jan; 27(1):36-43.
      View in: PubMed
    160. Aoki J, Kirtane AJ, Dangas GD, Lansky AJ, Morales A, Kimura M, Kim YH, Moussa I, Weisz G, Kreps EM, Collins M, Frankin-Bond T, Stone GW, Moses JW, Leon MB, Mehran R. Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings. Am J Cardiol. 2008 Jan 1; 101(1):58-62.
      View in: PubMed
    161. Pucelikova T, Mehran R, Kirtane AJ, Kim YH, Fahy M, Weisz G, Lansky AJ, Moussa I, Gray WA, Collins MB, Kodali SK, Stone GW, Moses JW, Leon MB, Dangas G. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. Am J Cardiol. 2008 Jan 1; 101(1):63-8.
      View in: PubMed
    162. Solinas E, Nikolsky E, Lansky AJ, Kirtane AJ, Morice MC, Popma JJ, Schofer J, Schampaert E, Pucelikova T, Aoki J, Fahy M, Dangas GD, Moses JW, Cutlip DE, Leon MB, Mehran R. Gender-specific outcomes after sirolimus-eluting stent implantation. J Am Coll Cardiol. 2007 Nov 27; 50(22):2111-6.
      View in: PubMed
    163. Obunai K, Jani S, Dangas GD. Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin North Am. 2007 Nov; 91(6):1169-84, x.
      View in: PubMed
    164. Sano K, Mintz GS, Carlier SG, Solinas E, Costa Jde R, Qian J, Missel E, Shan S, Franklin-Bond T, Boland P, Weisz G, Moussa I, Dangas G, Mehran R, Lansky AJ, Kreps E, Collins M, Stone GW, Moses JW, Leon MB. Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysis. J Invasive Cardiol. 2007 Nov; 19(11):464-8.
      View in: PubMed
    165. Mehran R, Dangas GD. Off-label use of drug-eluting stents: assessing the risk. Nat Clin Pract Cardiovasc Med. 2007 Nov; 4(11):594-5.
      View in: PubMed
    166. Sano K, Mintz GS, Carlier SG, de Ribamar Costa J, Qian J, Missel E, Shan S, Franklin-Bond T, Boland P, Weisz G, Moussa I, Dangas GD, Mehran R, Lansky AJ, Kreps EM, Collins MB, Stone GW, Leon MB, Moses JW. Assessing intermediate left main coronary lesions using intravascular ultrasound. Am Heart J. 2007 Nov; 154(5):983-8.
      View in: PubMed
    167. Nikolsky E, Mehran R, Dangas G, Fahy M, Na Y, Pocock SJ, Lincoff AM, Stone GW. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J. 2007 Aug; 28(16):1936-45.
      View in: PubMed
    168. de Ribamar Costa J, Mintz GS, Carlier SG, Mehran R, Teirstein P, Sano K, Liu X, Lui J, Na Y, Castellanos C, Biro S, Dani L, Rinker J, Moussa I, Dangas G, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon. Am J Cardiol. 2007 Sep 1; 100(5):812-7.
      View in: PubMed
    169. Nikolsky E, Pucelikova T, Mehran R, Balter S, Kaufman L, Fahy M, Lansky AJ, Leon MB, Moses JW, Stone GW, Dangas G. An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary intervention. J Invasive Cardiol. 2007 May; 19(5):208-13.
      View in: PubMed
    170. Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, Dangas GD, Lincoff AM, White HD, Moses JW, King SB, Ohman EM, Stone GW. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol. 2007 Mar 27; 49(12):1362-8.
      View in: PubMed
    171. Agahtehrani A, Dangas GD. Bolus-only glycoprotein IIb/IIIa inhibitor revisited. J Invasive Cardiol. 2006 Nov; 18(11):527.
      View in: PubMed
    172. Sano K, Mintz GS, Carlier SG, Fujii K, Takebayashi H, Kimura M, Costa JR, Tanaka K, Costa RA, Lui J, Weisz G, Moussa I, Dangas GD, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis. Am J Cardiol. 2006 Dec 15; 98(12):1559-62.
      View in: PubMed
    173. Weinberg MD, Hooper WC, Dangas G. Cardiac biomarkers for the prediction and diagnosis of atherosclerotic disease and its complications. Curr Mol Med. 2006 Aug; 6(5):557-69.
      View in: PubMed
    174. Jensen LO, Mintz GS, Carlier SG, Fujii K, Moussa I, Dangas G, Mehran R, Stone GW, Leon MB, Moses JW. Intravascular ultrasound assessment of fibrous cap remnants after coronary plaque rupture. Am Heart J. 2006 Aug; 152(2):327-32.
      View in: PubMed
    175. Tsuchiya Y, Lansky AJ, Costa RA, Mehran R, Pietras C, Shimada Y, Sonoda S, Cristea E, Negoita M, Dangas GD, Moses JW, Leon MB, Fitzgerald PJ, Müller R, Störger H, Hauptmann KE, Grube E. Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials). Am J Cardiol. 2006 Aug 15; 98(4):464-9.
      View in: PubMed
    176. Kimura M, Mintz GS, Carlier S, Takebayashi H, Fujii K, Sano K, Yasuda T, Costa RA, Costa JR, Quen J, Tanaka K, Lui J, Weisz G, Moussa I, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. Am J Cardiol. 2006 Aug 15; 98(4):436-42.
      View in: PubMed
    177. Lansky AJ, Yang YM, Khan Y, Costa RA, Pietras C, Tsuchiya Y, Cristea E, Collins M, Mehran R, Dangas GD, Moses JW, Leon MB, Stone GW. Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft. Am J Cardiol. 2006 Aug 1; 98(3):370-4.
      View in: PubMed
    178. Moses JW, Stone GW, Nikolsky E, Mintz GS, Dangas G, Grube E, Ellis SG, Lansky AJ, Weisz G, Fahy M, Na Y, Russell ME, Donohoe D, Leon MB, Mehran R. Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. J Am Coll Cardiol. 2006 Jun 6; 47(11):2164-71.
      View in: PubMed
    179. Sano K, Mintz GS, Carlier SG, Fujii K, Yasuda T, Kimura M, Costa JR, Costa RA, Lui J, Weisz G, Moussa I, Dangas GD, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass grafts. Am J Cardiol. 2006 May 15; 97(10):1463-6.
      View in: PubMed
    180. Moussa I, Costa RA, Leon MB, Lansky AJ, Lasic Z, Cristea E, Trubelja N, Carlier SG, Mehran R, Dangas GD, Weisz G, Kreps EM, Collins M, Stone GW, Moses JW. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique". Am J Cardiol. 2006 May 1; 97(9):1317-21.
      View in: PubMed
    181. Mehran R, Dangas G. Can manual thrombus aspiration improve myocardial reperfusion? Nat Clin Pract Cardiovasc Med. 2006 Feb; 3(2):68-9.
      View in: PubMed
    182. Iakovou I, Mehran R, Dangas G. Thrombosis after implantation of drug-eluting stents. Hellenic J Cardiol. 2006 Jan-Feb; 47(1):31-8.
      View in: PubMed
    183. Stone GW, Reifart NJ, Moussa I, Hoye A, Cox DA, Colombo A, Baim DS, Teirstein PS, Strauss BH, Selmon M, Mintz GS, Katoh O, Mitsudo K, Suzuki T, Tamai H, Grube E, Cannon LA, Kandzari DE, Reisman M, Schwartz RS, Bailey S, Dangas G, Mehran R, Abizaid A, Moses JW, Leon MB, Serruys PW. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II. Circulation. 2005 Oct 18; 112(16):2530-7.
      View in: PubMed
    184. Stone GW, Kandzari DE, Mehran R, Colombo A, Schwartz RS, Bailey S, Moussa I, Teirstein PS, Dangas G, Baim DS, Selmon M, Strauss BH, Tamai H, Suzuki T, Mitsudo K, Katoh O, Cox DA, Hoye A, Mintz GS, Grube E, Cannon LA, Reifart NJ, Reisman M, Abizaid A, Moses JW, Leon MB, Serruys PW. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation. 2005 Oct 11; 112(15):2364-72.
      View in: PubMed
    185. Stone GW, Colombo A, Teirstein PS, Moses JW, Leon MB, Reifart NJ, Mintz GS, Hoye A, Cox DA, Baim DS, Strauss BH, Selmon M, Moussa I, Suzuki T, Tamai H, Katoh O, Mitsudo K, Grube E, Cannon LA, Kandzari DE, Reisman M, Schwartz RS, Bailey S, Dangas G, Mehran R, Abizaid A, Serruys PW. Percutaneous recanalization of chronically occluded coronary arteries: procedural techniques, devices, and results. Catheter Cardiovasc Interv. 2005 Oct; 66(2):217-36.
      View in: PubMed
    186. Dangas G, Moses JW. Is surgery preferred for the diabetic with multivessel disease? Debate on revascularization strategy for diabetic patients with multivessel coronary artery disease. Circulation. 2005 Sep 6; 112(10):1507-13; discussion 1514.
      View in: PubMed
    187. Dangas G, Lasic Z, Mehran R, Cox D, Ghali MG, Henry TD, Teirstein PS, Stella JF, Browne KF, Lewis SA, Knopf W, Leon MB, Moses JW, Stone GW. Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study). Am J Cardiol. 2005 Sep 1; 96(5):659-63.
      View in: PubMed
    188. Costa RA, Mintz GS, Carlier SG, Lansky AJ, Moussa I, Fujii K, Takebayashi H, Yasuda T, Costa JR, Tsuchiya Y, Jensen LO, Cristea E, Mehran R, Dangas GD, Iyer S, Collins M, Kreps EM, Colombo A, Stone GW, Leon MB, Moses JW. Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. J Am Coll Cardiol. 2005 Aug 16; 46(4):599-605.
      View in: PubMed
    189. Teirstein PS, Kao J, Watkins M, Tannenbaum MA, Laufer N, Chang M, Mehran R, Dangas G, Russell ME, Ellis SG, Stone GW. Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy). Am J Cardiol. 2005 Aug 15; 96(4):500-5.
      View in: PubMed
    190. Fujii K, Carlier SG, Mintz GS, Takebayashi H, Yasuda T, Costa RA, Moussa I, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Intravascular ultrasound study of patterns of calcium in ruptured coronary plaques. Am J Cardiol. 2005 Aug 1; 96(3):352-7.
      View in: PubMed
    191. de Ribamar Costa J, Mintz GS, Carlier SG, Costa RA, Fujii K, Sano K, Kimura M, Lui J, Weisz G, Moussa I, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts. Am J Cardiol. 2005 Jul 1; 96(1):74-8.
      View in: PubMed
    192. Dangas G, Ellis SG, Shlofmitz R, Katz S, Fish D, Martin S, Mehran R, Russell ME, Stone GW. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. J Am Coll Cardiol. 2005 Apr 19; 45(8):1186-92.
      View in: PubMed
    193. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005 Apr 5; 45(7):995-8.
      View in: PubMed
    194. Kipshidze NN, Porter TR, Dangas G, Yazdi H, Tio F, Xie F, Hellinga D, Wolfram R, Seabron R, Waksman R, Abizaid A, Roubin G, Iyer S, Colombo A, Leon MB, Moses JW, Iversen P. Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model. Catheter Cardiovasc Interv. 2005 Mar; 64(3):389-94.
      View in: PubMed
    195. Takebayashi H, Kobayashi Y, Mintz GS, Carlier SG, Fujii K, Yasuda T, Moussa I, Mehran R, Dangas GD, Collins MB, Kreps E, Lansky AJ, Stone GW, Leon MB, Moses JW. Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. Am J Cardiol. 2005 Feb 15; 95(4):498-502.
      View in: PubMed
    196. Fujii K, Carlier SG, Mintz GS, Kobayashi Y, Jacoboff D, Nierenberg H, Takebayashi H, Yasuda T, Moussa I, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Leon MB, Moses JW. Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque. Am J Cardiol. 2005 Feb 1; 95(3):355-9.
      View in: PubMed
    197. Nikolsky E, Mehran R, Lasic Z, Mintz GS, Lansky AJ, Na Y, Pocock S, Negoita M, Moussa I, Stone GW, Moses JW, Leon MB, Dangas G. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int. 2005 Feb; 67(2):706-13.
      View in: PubMed
    198. Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB, Mehran R. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005 Jan 1; 95(1):13-9.
      View in: PubMed
    199. Costa RA, Lansky AJ, Mintz GS, Mehran R, Tsuchiya Y, Negoita M, Gilutz Y, Nikolsky E, Fahy M, Pop R, Cristea E, Carlier S, Dangas G, Stone GW, Leon MB, Müller R, Techen G, Grube E. Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial). Am J Cardiol. 2005 Jan 1; 95(1):113-6.
      View in: PubMed
    200. Lasic Z, Nikolsky E, Kesanakurthy S, Dangas G. Vascular closure devices: a review of their use after invasive procedures. Am J Cardiovasc Drugs. 2005; 5(3):185-200.
      View in: PubMed
    201. Yang YM, Mehran R, Dangas G, Reyes A, Qin J, Stone GW, Leon MB, Moses JW. Successful use of the frontrunner catheter in the treatment of in-stent coronary chronic total occlusions. Catheter Cardiovasc Interv. 2004 Dec; 63(4):462-8.
      View in: PubMed
    202. Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda T, Costa RA, Moussa I, Dangas GD, Mehran R, Lansky AJ, Kreps E, Collins MB, Colombo A, Stone GW, Leon MB, Moses JW. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation. 2004 Nov 30; 110(22):3430-4.
      View in: PubMed
    203. Stone GW, Bertrand M, Colombo A, Dangas G, Farkouh ME, Feit F, Lansky AJ, Lincoff AM, Mehran R, Moses JW, Ohman M, White HD. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale. Am Heart J. 2004 Nov; 148(5):764-75.
      View in: PubMed
    204. Fujii K, Mintz GS, Kobayashi Y, Carlier SG, Takebayashi H, Jacoboff D, Yasuda T, Moussa I, Dangas G, Mehran R, Lansky AJ, Reyes A, Kreps E, Collins M, Stone GW, Leon MB, Moses JW. Vascular remodeling and plaque composition between focal and diffuse coronary lesions assessed by intravascular ultrasound. Am J Cardiol. 2004 Oct 15; 94(8):1067-70.
      View in: PubMed
    205. Dangas G, Aymong ED, Mehran R, Tcheng JE, Grines CL, Cox DA, Garcia E, Griffin JJ, Guagliumi G, Stuckey T, Lansky AJ, Stone GW. Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial). Am J Cardiol. 2004 Oct 15; 94(8):983-8.
      View in: PubMed
    206. Nikolsky E, Mehran R, Aymong ED, Mintz GS, Lansky AJ, Lasic Z, Negoita M, Fahy M, Pocock SJ, Na Y, Krieger S, Moses JW, Stone GW, Leon MB, Dangas G. Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol. 2004 Oct 15; 94(8):1023-7.
      View in: PubMed
    207. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004 Oct 6; 44(7):1393-9.
      View in: PubMed
    208. Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z, Negoita M, Fahy M, Krieger S, Moussa I, Moses JW, Stone GW, Leon MB, Pocock SJ, Dangas G. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004 Sep 15; 44(6):1200-9.
      View in: PubMed
    209. Nikolsky E, Dangas G. Clopidogrel loading dose pre-PCI: how high? J Invasive Cardiol. 2004 Sep; 16(9):551-2.
      View in: PubMed
    210. Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon MB, Kutryk M, Serruys P. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol. 2004 Aug 18; 44(4):733-9.
      View in: PubMed
    211. Nikolsky E, Mehran R, Turcot D, Aymong ED, Mintz GS, Lasic Z, Lansky AJ, Tsounias E, Moses JW, Stone GW, Leon MB, Dangas GD. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol. 2004 Aug 1; 94(3):300-5.
      View in: PubMed
    212. Iakovou I, Mehran R, Dangas G, Lansky AJ, Stone GW, Mintz GS, Aymong E, Ashby DT, Pichard AD, Satler LF, Kent K, Leon MB, Waksman R. Favorable effect of gamma-radiation for in-stent restenosis: effect of diabetes on angiographic and clinical outcomes. Catheter Cardiovasc Interv. 2004 Jul; 62(3):303-7.
      View in: PubMed
    213. Lasic Z, Mehran R, Dangas G, Mintz G, Nikolsky E, Tsounias E, Udani PC, Adamian M, Adamian J, Moussa I, Collins M, Stone G, Moses J. Comparison of safety and efficacy between first and second generation of angio-seal closure devices in interventional patients. J Invasive Cardiol. 2004 Jul; 16(7):356-8.
      View in: PubMed
    214. Nikolsky E, Mehran R, Dangas GD, Lasic Z, Mintz GS, Negoita M, Lansky AJ, Stone GW, Moussa I, Iyer S, Na Y, Moses JW, Leon MB. Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions. Am J Cardiol. 2004 Jun 15; 93(12):1536-9.
      View in: PubMed
    215. Nikolsky E, Dangas GD. Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia. Semin Thromb Hemost. 2004 Jun; 30(3):305-14.
      View in: PubMed
    216. Mehran R, Dangas GD, Kobayashi Y, Lansky AJ, Mintz GS, Aymong ED, Fahy M, Moses JW, Stone GW, Leon MB. Short- and long-term results after multivessel stenting in diabetic patients. J Am Coll Cardiol. 2004 Apr 21; 43(8):1348-54.
      View in: PubMed
    217. Iakovou I, Dangas G, Mintz GS, Mehran R, Kobayashi Y, D Aymong E, Hirose M, Ashby DT, Lansky AJ, Stone GW, Leon MB, Moses JW. Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome. Am J Cardiol. 2004 Apr 15; 93(8):963-8.
      View in: PubMed
    218. Shirai K, Lansky AJ, Mehran R, Dangas GD, Costantini CO, Fahy M, Slack S, Mintz GS, Stone GW, Leon MB. Minimally invasive coronary artery bypass grafting versus stenting for patients with proximal left anterior descending coronary artery disease. Am J Cardiol. 2004 Apr 15; 93(8):959-62.
      View in: PubMed
    219. Kipshidze NN, Iversen P, Kim HS, Yiazdi H, Dangas G, Seaborn R, New G, Tio F, Waksman R, Mehran R, Tsapenko M, Stone GW, Roubin GS, Iyer S, Leon MB, Moses JW. Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model. Catheter Cardiovasc Interv. 2004 Apr; 61(4):518-27.
      View in: PubMed
    220. Lansky AJ, Mehran R, Dangas G, Cristea E, Shirai K, Costa R, Costantini C, Tsuchiya Y, Carlier S, Mintz G, Cottin Y, Stone G, Moses J, Leon MB. Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age. Am J Cardiol. 2004 Apr 1; 93(7):916-9.
      View in: PubMed
    221. Fujii K, Mintz GS, Kobayashi Y, Carlier SG, Takebayashi H, Yasuda T, Moussa I, Dangas G, Mehran R, Lansky AJ, Reyes A, Kreps E, Collins M, Colombo A, Stone GW, Teirstein PS, Leon MB, Moses JW. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation. 2004 Mar 9; 109(9):1085-8.
      View in: PubMed
    222. Mehran R, Iakovou I, Dangas G, Lansky AJ, Stone GW, Mintz GS, Kent KM, Pichard AD, Satler LF, Fahy M, Leon MB, Waksman R. Gamma radiation for in-stent restenosis: effect of lesion length on angiographic and clinical outcomes. Catheter Cardiovasc Interv. 2004 Mar; 61(3):354-9.
      View in: PubMed
    223. Iakovou I, Dangas G, Mintz GS, Mehran R, Lansky AJ, Aymong ED, Nikolsky E, Vagaonescu T, Glasser LA, Stone GW, Leon MB, Moses JW. Comparison of frequency of hemorrhagic stroke in patients <75 years versus > or =75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions. Am J Cardiol. 2004 Feb 1; 93(3):346-9.
      View in: PubMed
    224. Nikolsky E, Mehran R, Mintz GS, Dangas GD, Lansky AJ, Aymong ED, Negoita M, Fahy M, Moussa I, Roubin GS, Moses JW, Stone GW, Leon MB. Impact of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing percutaneous coronary interventions. J Endovasc Ther. 2004 Feb; 11(1):60-70.
      View in: PubMed
    225. Shirai K, Lansky AJ, Mintz GS, Costantini CO, Fahy M, Mehran R, Dangas G, Moses JW, Stone GW, Waksman R, Leon MB. Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis. Am J Cardiol. 2003 Dec 15; 92(12):1409-13.
      View in: PubMed
    226. Iakovou I, Mintz GS, Dangas G, Abizaid A, Mehran R, Kobayashi Y, Lansky AJ, Aymong ED, Nikolsky E, Stone GW, Moses JW, Leon MB. Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2003 Dec 3; 42(11):1900-5.
      View in: PubMed
    227. Takebayashi H, Kobayashi Y, Dangas G, Fujii K, Mintz GS, Stone GW, Moses JW, Leon MB. Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion. Catheter Cardiovasc Interv. 2003 Dec; 60(4):496-9.
      View in: PubMed
    228. Kobayashi Y, Mehran R, Mintz GS, Dangas G, Moussa I, Collins M, Brara P, Moussavian M, Lansky AJ, Stone GW, Leon MB, Moses JW, Teirstein PS. Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis. Am J Cardiol. 2003 Dec 1; 92(11):1329-31.
      View in: PubMed
    229. Costantini CO, Lansky AJ, Mintz GS, Shirai K, Dangas G, Mehran R, Stone GW, Leon MB. Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapy. Am J Cardiol. 2003 Nov 15; 92(10):1214-7.
      View in: PubMed
    230. Iakovou I, Mintz GS, Dangas G, Abizaid A, Mehran R, Lansky AJ, Kobayashi Y, Hirose M, Ashby DT, Stone GW, Moses JW, Leon MB. Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries. Am J Cardiol. 2003 Nov 15; 92(10):1171-6.
      View in: PubMed
    231. Fujii K, Kobayashi Y, Mintz GS, Takebayashi H, Dangas G, Moussa I, Mehran R, Lansky AJ, Kreps E, Collins M, Colombo A, Stone GW, Leon MB, Moses JW. Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes. Circulation. 2003 Nov 18; 108(20):2473-8.
      View in: PubMed
    232. Iakovou I, Dangas G, Mehran R, Mintz GS, Lansky AJ, Aymong ED, Nikolsky E, Vagaonescu T, Glasser LA, Stone GW, Leon MB, Moses JW. Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients >or=75 years of age versus those <75 years of age. Am J Cardiol. 2003 Nov 1; 92(9):1083-6.
      View in: PubMed
    233. Dangas G, Nikolsky E. PCI options in heparin-induced thrombocytopenia. J Invasive Cardiol. 2003 Nov; 15(11):622-3.
      View in: PubMed
    234. Dangas G. Editorial comment--Hypotension after carotid revascularization. Stroke. 2003 Nov; 34(11):2581-2.
      View in: PubMed
    235. Dangas G. Interventional therapy for acute myocardial infarction: respect the microvasculature. J Am Coll Cardiol. 2003 Oct 15; 42(8):1403-5.
      View in: PubMed
    236. Kobayashi Y, Mehran R, Mintz GS, Dangas G, Moussa I, Lansky AJ, Stone GW, Moses JW, Leon MB. Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years old. Am J Cardiol. 2003 Aug 15; 92(4):443-6.
      View in: PubMed
    237. Limpijankit T, Mehran R, Mintz GS, Dangas G, Lansky AJ, Kao J, Ashby DT, Moussa I, Stone GW, Moses JW, Leon MB, Teirstein PS. Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III). Am J Cardiol. 2003 Aug 1; 92(3):315-8.
      View in: PubMed
    238. Ashby DT, Dangas G, Aymong EA, Farkouh ME, Mehran R, Lansky AJ, Moses JW, Leon MB, Stone GW. Relation between the degree of procedural anticoagulation and complications after coronary stent implantation. Am J Cardiol. 2003 Aug 1; 92(3):319-22.
      View in: PubMed
    239. Hirose M, Kobayashi Y, Mintz GS, Moussa I, Mehran R, Lansky AJ, Dangas G, Kreps EM, Collins MB, Stone GW, Colombo A, Leon MB, Moses JW. Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%. Am J Cardiol. 2003 Jul 15; 92(2):141-5.
      View in: PubMed
    240. Kipshidze NN, Porter TR, Dangas G, Yazdi H, Tio F, Xie F, Hellinga D, Fournadjiev J, Wolfram R, Seabron R, Waksman R, Abizaid A, Roubin G, Iyer S, Leon MB, Moses JW, Iversen P. Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model. Cardiovasc Radiat Med. 2003 Jul-Sep; 4(3):152-9.
      View in: PubMed
    241. Fujii K, Kobayashi Y, Mintz GS, Hirose M, Moussa I, Mehran R, Dangas G, Lansky AJ, Kreps E, Collins M, Colombo A, Stone GW, Leon MB, Moses JW. Dominant contribution of negative remodeling to development of significant coronary bifurcation narrowing. Am J Cardiol. 2003 Jul 1; 92(1):59-61.
      View in: PubMed
    242. Costantini CO, Lansky AJ, Mintz GS, Shirai K, Dangas G, Mehran R, Fahy M, Slack S, Coral M, Teirstein PS, Waksman R, Stone G, Moses J, Leon MB. Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions. J Am Coll Cardiol. 2003 May 21; 41(10):1725-31.
      View in: PubMed
    243. Ashby DT, Mehran R, Aymong EA, Lansky AJ, Iakovou I, Weisz G, New G, Moussa I, Dangas G, Moses JW, Stone GW, Leon MB. Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries. Am J Cardiol. 2003 Apr 15; 91(8):979-81, A4, A7.
      View in: PubMed
    244. Dangas G, Iakovou I. Pulmonary hemorrhage during GP IIb/IIIa inhibitor therapy: an uncommon but life-threatening (and under-recognized) complication. J Invasive Cardiol. 2003 Apr; 15(4):189-90.
      View in: PubMed
    245. Ashby DT, Dangas G, Aymong EA, Iakovou I, Kuepper F, Mehran R, Stone GW, Leon MB, Moses JW. Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection. J Am Coll Cardiol. 2003 Mar 5; 41(5):749-52.
      View in: PubMed
    246. D Agate DJ, Kokolis S, Belilos E, Carsons S, Andrieni J, Argyros T, Glasser LA, Dangas G. Premature coronary artery disease in systemic lupus erythematosus with extensive reocclusion following coronary artery bypass surgery. J Invasive Cardiol. 2003 Mar; 15(3):157-63.
      View in: PubMed
    247. Kroumpouzou E, Gomatos IP, Kataki A, Karayannis M, Dangas GD, Toutouzas P. Common pathways for primary hypertrophic and dilated cardiomyopathy. Hybrid Hybridomics. 2003 Feb; 22(1):41-5.
      View in: PubMed
    248. Kuepper F, Dangas G, Mueller-Chorus A, Kulka PM, Zenz M, Wiebalck A. Fibrinolytic activity and bleeding after cardiac surgery with cardiopulmonary bypass and low-dose aprotinin therapy. Blood Coagul Fibrinolysis. 2003 Feb; 14(2):147-53.
      View in: PubMed
    249. El-Omar MM, Dangas G, Mehran R, Lansky AJ, Kipshidze NN, Polena S, Fahy M, Moussa I, Glasser L, Moses JW, Stone GW, Leon MB. Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention. Am J Cardiol. 2003 Jan 15; 91(2):232-4.
      View in: PubMed
    250. Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, Mintz GS, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol. 2003 Jan; 15(1):18-22.
      View in: PubMed
    251. Chekanov VS, Nikolaychik V, Maternowski MA, Mehran R, Leon MB, Adamian M, Moses J, Dangas G, Kipshidze N, Akhtar M. Deferoxamine enhances neovascularization and recovery of ischemic skeletal muscle in an experimental sheep model. Ann Thorac Surg. 2003 Jan; 75(1):184-9.
      View in: PubMed
    252. Nikolsky E, Aymong ED, Dangas G, Mehran R. Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function. Rev Cardiovasc Med. 2003; 4 Suppl 1:S7-S14.
      View in: PubMed
    253. Chekanov V, Akhtar M, Tchekanov G, Dangas G, Shehzad MZ, Tio F, Adamian M, Colombo A, Roubin G, Leon MB, Moses JW, Kipshidze NN. Transplantation of autologous endothelial cells induces angiogenesis. Pacing Clin Electrophysiol. 2003 Jan; 26(1 Pt 2):496-9.
      View in: PubMed
    254. Ashby DT, Conditt G, Hirose M, Dangas G. Coronary artery spasm associated with a moderately severe atherosclerotic stenosis in the proximal LAD. J Invasive Cardiol. 2002 Dec; 14(12):770-2.
      View in: PubMed
    255. Iakovou I, Dangas G, Mehran R, Lansky AJ, Stamou SC, Pfister AJ, Dullum MK, Leon MB, Corso PJ. Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending artery. Am J Cardiol. 2002 Oct 15; 90(8):885-7.
      View in: PubMed
    256. Vagaonescu TD, Dangas G. How to diagnose, how to treat: renal artery stenosis-diagnosis and management. J Clin Hypertens (Greenwich). 2002 Sep-Oct; 4(5):363-70.
      View in: PubMed
    257. Dangas G, Kuepper F. Cardiology patient page. Restenosis: repeat narrowing of a coronary artery: prevention and treatment. Circulation. 2002 Jun 4; 105(22):2586-7.
      View in: PubMed
    258. Dangas G, Costantini CO. Editorial commentary: in-stent restenosis and cutting balloon. J Invasive Cardiol. 2002 Jun; 14(6):297-8.
      View in: PubMed
    259. Ashby DT, Dangas G, Mehran R, Lansky AJ, Narasimaiah R, Iakovou I, Polena S, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries. Am J Cardiol. 2002 May 15; 89(10):1162-6.
      View in: PubMed
    260. Kipshidze NN, Kim HS, Iversen P, Yazdi HA, Bhargava B, New G, Mehran R, Tio F, Haudenschild C, Dangas G, Stone GW, Iyer S, Roubin GS, Leon MB, Moses JW. Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model. J Am Coll Cardiol. 2002 May 15; 39(10):1686-91.
      View in: PubMed
    261. Ashby DT, Dangas G, Mehran R, Leon MB. Coronary artery stenting. Catheter Cardiovasc Interv. 2002 May; 56(1):83-102.
      View in: PubMed
    262. Lansky AJ, Mehran R, Dangas G, Desai K, Costantini-Ortiz C, Cristea E, New G, Negoita M, Stone GW, Leon MB. New-device angioplasty in women: clinical outcome and predictors in a 7,372-patient registry. Epidemiology. 2002 May; 13 Suppl 3:S46-51.
      View in: PubMed
    263. Iakovou I, Dangas G, Mehran R, Lansky AJ, Kobayashi Y, Adamian M, Polena S, Collins MB, Roubin GS, Stone GW, Leon MB, Moses JW. Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors. Am J Cardiol. 2002 Apr 15; 89(8):976-9.
      View in: PubMed
    264. Dangas G, Mehran R, Feldman D, Stoyioglou A, Pichard AD, Kent KM, Satler LF, Fahy M, Lansky AJ, Stone GW, Leon MB. Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention. Am J Cardiol. 2002 Mar 1; 89(5):586-9.
      View in: PubMed
    265. Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol. 2002 Feb 20; 39(4):591-7.
      View in: PubMed
    266. Lansky AJ, Dangas G, Mehran R, Desai KJ, Mintz GS, Wu H, Fahy M, Stone GW, Waksman R, Leon MB. Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation. J Am Coll Cardiol. 2002 Jan 16; 39(2):274-80.
      View in: PubMed
    267. Ashby DT, Dangas G, Mehran R, Lansky AJ, Fahy MP, Iakovou I, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Comparison of one-year outcomes after percutaneous coronary intervention among current smokers, ex-smokers, and nonsmokers. Am J Cardiol. 2002 Jan 15; 89(2):221-4.
      View in: PubMed
    268. Bhatt DL, Bertrand ME, Berger PB, L'Allier PL, Moussa I, Moses JW, Dangas G, Taniuchi M, Lasala JM, Holmes DR, Ellis SG, Topol EJ. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol. 2002 Jan 2; 39(1):9-14.
      View in: PubMed
    269. Gruberg L, Dangas G, Mehran R, Mintz GS, Kent KM, Pichard AD, Satler LF, Lansky AJ, Stone GW, Leon MB. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv. 2002 Jan; 55(1):66-72.
      View in: PubMed
    270. Kipshidze N, Iversen P, Keane E, Stein D, Chawla P, Skrinska V, Shankar LR, Mehran R, Chekanov V, Dangas G, Komorowski R, Haudenschild C, Khanna A, Leon M, Keelan MH, Moses J. Complete vascular healing and sustained suppression of neointimal thickening after local delivery of advanced c-myc antisense at six months follow-up in a rabbit balloon injury model. Cardiovasc Radiat Med. 2002 Jan-Mar; 3(1):26-30.
      View in: PubMed
    271. Kobayashi Y, Moussa I, Dangas G, Mehran R, Desai K, Adamian M, Collins M, Kreps E, Stone GW, Leon MB, Moses JW. Acute angiographic and clinical results of the NIR w/SOX stent. J Invasive Cardiol. 2002 Jan; 14(1):14-8.
      View in: PubMed
    272. Dangas G. Aspirin plus clopidogrel for everyone: panacea comes true in the 21st century. J Invasive Cardiol. 2001 Dec; 13(12):772-3.
      View in: PubMed
    273. Dangas G, Iakovou I. The end of systemic anticoagulation therapy for restenosis prevention. J Invasive Cardiol. 2001 Nov; 13(11):729-31.
      View in: PubMed
    274. Kipshidze N, Nikolaychik V, Muckerheidi M, Keelan MH, Chekanov V, Maternowski M, Chawla P, Hernandez I, Iyer S, Dangas G, Sahota H, Leon MB, Roubin G, Moses JW. Effect of short pulsed nonablative infrared laser irradiation on vascular cells in vitro and neointimal hyperplasia in a rabbit balloon injury model. Circulation. 2001 Oct 9; 104(15):1850-5.
      View in: PubMed
    275. Dangas G, Mehran R, Kokolis S, Feldman D, Satler LF, Pichard AD, Kent KM, Lansky AJ, Stone GW, Leon MB. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol. 2001 Sep; 38(3):638-41.
      View in: PubMed
    276. Stone GW, Mehran R, Dangas G, Lansky AJ, Kornowski R, Leon MB. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation. 2001 Aug 7; 104(6):642-7.
      View in: PubMed
    277. Stamou SC, Hill PC, Dangas G, Pfister AJ, Boyce SW, Dullum MK, Bafi AS, Corso PJ. Stroke after coronary artery bypass: incidence, predictors, and clinical outcome. Stroke. 2001 Jul; 32(7):1508-13.
      View in: PubMed
    278. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky A, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol. 2001 Jul; 38(1):150-4.
      View in: PubMed
    279. Gruberg L, Mehran R, Waksman R, Dangas G, Fuchs S, Wu H, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure. Am J Cardiol. 2001 Jun 15; 87(12):1356-60.
      View in: PubMed
    280. Dangas G, Laird JR, Mehran R, Lansky AJ, Mintz GS, Leon MB. Intravascular ultrasound-guided renal artery stenting. J Endovasc Ther. 2001 Jun; 8(3):238-47.
      View in: PubMed
    281. Steinhubl SR, Talley JD, Braden GA, Tcheng JE, Casterella PJ, Moliterno DJ, Navetta FI, Berger PB, Popma JJ, Dangas G, Gallo R, Sane DC, Saucedo JF, Jia G, Lincoff AM, Theroux P, Holmes DR, Teirstein PS, Kereiakes DJ. Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation. 2001 May 29; 103(21):2572-8.
      View in: PubMed
    282. Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, Pichard AD, Satler LF, Wu H, Leon MB. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv. 2001 Apr; 52(4):409-16.
      View in: PubMed
    283. Mehran R, Dangas G, Abizaid A, Lansky AJ, Mintz GS, Pichard AD, Satler LF, Kent KM, Waksman R, Stone GW, Leon MB. Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results. Am Heart J. 2001 Apr; 141(4):610-4.
      View in: PubMed
    284. Dangas G, Monsein LH, Laureno R, Peterson MA, Laird JR, Satler LF, Mehran R, Leon MB. Transient contrast encephalopathy after carotid artery stenting. J Endovasc Ther. 2001 Apr; 8(2):111-3.
      View in: PubMed
    285. Dangas G. Prognostic importance of myonecrosis after percutaneous coronary interventions. J Invasive Cardiol. 2001 Mar; 13(3):247-50; discussion 266-70.
      View in: PubMed
    286. Ahmed JM, Dangas G, Lansky AJ, Mehran R, Hong MK, Mintz GS, Pichard AD, Satler LF, Kent KM, Stone GW, Leon MB. Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting. Am J Cardiol. 2001 Feb 15; 87(4):401-5.
      View in: PubMed
    287. Dangas G, Mehran R, Abizaid AS, Curry BH, Lansky AJ, Kent KM, Pichard AD, Satler LF, Paliou M, Stone GW, Leon MB. Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting. Am J Cardiol. 2001 Feb 15; 87(4):470-2, A7.
      View in: PubMed
    288. Mintz GS, Kimura T, Nobuyoshi M, Dangas G, Leon MB. Relation between preintervention remodeling and late arterial responses to coronary angioplasty or atherectomy. Am J Cardiol. 2001 Feb 15; 87(4):392-6.
      View in: PubMed
    289. Dangas G, Laird JR, Mehran R, Satler LF, Lansky AJ, Mintz G, Monsein LH, Laureno R, Leon MB. Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomy. J Endovasc Ther. 2001 Feb; 8(1):39-43.
      View in: PubMed
    290. Degeare VS, Dangas G, Stone GW, Grines CL. Interventional procedures in acute myocardial infarction. Am Heart J. 2001 Jan; 141(1):15-24.
      View in: PubMed
    291. Mehran R, Dangas G, Stamou SC, Pfister AJ, Dullum MK, Leon MB, Corso PJ. One-year clinical outcome after minimally invasive direct coronary artery bypass. Circulation. 2000 Dec 5; 102(23):2799-802.
      View in: PubMed
    292. Dangas G, Kobayashi Y. Are small vessels "truly" small? J Invasive Cardiol. 2000 Dec; 12(12):631-2.
      View in: PubMed
    293. Dangas G, Mehran R, Lansky AJ, Waksman R, Satler LF, Pichard AD, Kent KM, Mintz GS, Stone GW, Leon MB. Acute and long-term results of treatment of diffuse in-stent restenosis in aortocoronary saphenous vein grafts. Am J Cardiol. 2000 Oct 1; 86(7):777-9, A6.
      View in: PubMed
    294. Ahmed JM, Hong MK, Mehran R, Dangas G, Mintz GS, Pichard AD, Satler LF, Kent KM, Wu H, Stone GW, Leon MB. Influence of diabetes mellitus on early and late clinical outcomes in saphenous vein graft stenting. J Am Coll Cardiol. 2000 Oct; 36(4):1186-93.
      View in: PubMed
    295. Dangas G, Mintz GS, Mehran R, Ahmed JM, Lansky AJ, Pichard AD, Satler LF, Kent KM, Stone GW, Leon MB. Stent implantation neutralizes the impact of preintervention arterial remodeling on subsequent target lesion revascularization. Am J Cardiol. 2000 Aug 15; 86(4):452-5.
      View in: PubMed
    296. Ambrose JA, Hawkey M, Badimon JJ, Coppola J, Geagea J, Rentrop KP, Domiguez A, Duvvuri S, Elmquist T, Arias J, Doss R, Dangas G. In vivo demonstration of an antithrombin effect of abciximab. Am J Cardiol. 2000 Jul 15; 86(2):150-2.
      View in: PubMed
    297. Dangas G, Machac J, Goldman ME, Sharma SK, Shao JH, Cohen AM, Meraj P, Feldman D, Ambrose JA. Evaluation of myocardial viability in asymptomatic patients early after infarction with perfusion/metabolism single-photon-emission computed tomographic imaging and dobutamine echocardiography. Coron Artery Dis. 2000 Jul; 11(5):409-14.
      View in: PubMed
    298. Stamou SC, Dangas G, Hill PC, Pfister AJ, Dullum MK, Boyce SW, Bafi AS, Garcia JM, Corso PJ. Atrial fibrillation after beating heart surgery. Am J Cardiol. 2000 Jul 1; 86(1):64-7.
      View in: PubMed
    299. Dangas G, Laird JR, Satler LF, Mehran R, Mintz GS, Larrain G, Lansky AJ, Gruberg L, Parsons EM, Laureno R, Monsein LH, Leon MB. Postprocedural hypotension after carotid artery stent placement: predictors and short- and long-term clinical outcomes. Radiology. 2000 Jun; 215(3):677-83.
      View in: PubMed
    300. Mehran R, Dangas G, Mintz GS, Waksman R, Abizaid A, Satler LF, Pichard AD, Kent KM, Lansky AJ, Stone GW, Leon MB. Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: comparative mechanisms and results. Circulation. 2000 May 30; 101(21):2484-9.
      View in: PubMed
    301. Hayes R, Chesebro JH, Fuster V, Dangas G, Fallon JT, Sharma SK, Coller BS, Badimon L, Marmur JD, Badimon JJ. Antithrombotic effects of abciximab. Am J Cardiol. 2000 May 15; 85(10):1167-72.
      View in: PubMed
    302. Stamou SC, Pfister AJ, Dangas G, Dullum MK, Boyce SW, Bafi AS, Garcia JM, Corso PJ. Beating heart versus conventional single-vessel reoperative coronary artery bypass. Ann Thorac Surg. 2000 May; 69(5):1383-7.
      View in: PubMed
    303. Dangas G, Smith DA, Unger AH, Shao JH, Meraj P, Fier C, Cohen AM, Fallon JT, Badimon JJ, Ambrose JA. Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effect. Thromb Haemost. 2000 May; 83(5):688-92.
      View in: PubMed
    304. Dangas G, Ambrose JA, Rehmann D, Marmur JD, Sharma SK, Hemdal-Monsen C, Sanborn TA, Fischman DL. Balloon optimization versus stent study (BOSS): provisional stenting and early recoil after balloon angioplasty. Am J Cardiol. 2000 Apr 15; 85(8):957-61.
      View in: PubMed
    305. Dangas G, Konstadoulakis MM, Epstein SE, Stefanadis CI, Kymionis GD, Toutouza MG, Liakos C, Sadaniantz A, Cohen AM, Chesebro JH, Toutouzas PK. Prevalence of autoantibodies against contractile proteins in coronary artery disease and their clinical implications. Am J Cardiol. 2000 Apr 1; 85(7):870-2, A6, A9.
      View in: PubMed
    306. Saucedo JF, Mehran R, Dangas G, Hong MK, Lansky A, Kent KM, Satler LF, Pichard AD, Stone GW, Leon MB. Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol. 2000 Apr; 35(5):1134-41.
      View in: PubMed
    307. Stamou SC, Dangas G, Dullum MK, Pfister AJ, Boyce SW, Bafi AS, Garcia JM, Corso PJ. Beating heart surgery in octogenarians: perioperative outcome and comparison with younger age groups. Ann Thorac Surg. 2000 Apr; 69(4):1140-5.
      View in: PubMed
    308. Gruberg L, Dangas G, Mehran R, Hong MK, Waksman R, Mintz GS, Kent KM, Pichard AD, Satler LF, Lansky AJ, Stone GW, Leon MB. Percutaneous revascularization of the internal mammary artery graft: short- and long-term outcomes. J Am Coll Cardiol. 2000 Mar 15; 35(4):944-8.
      View in: PubMed
    309. Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Satler LF, Kent KM, Stone GW, Leon MB. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions : intravascular ultrasound study of 2256 patients. Circulation. 2000 Feb 15; 101(6):604-10.
      View in: PubMed
    310. Gruberg L, Hong MK, Mintz GS, Mehran R, Waksman R, Dangas G, Kent KM, Pichard AD, Satler LF, Lansky AJ, Kornowski R, Stone GW, Leon MB. Optimally deployed stents in the treatment of restenotic versus de novo lesions. Am J Cardiol. 2000 Feb 1; 85(3):333-7.
      View in: PubMed
    311. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky A, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB. Comparison of time course of target lesion revascularization following successful saphenous vein graft angioplasty versus successful native coronary angioplasty. Am J Cardiol. 2000 Jan 15; 85(2):256-8.
      View in: PubMed
    312. Ambrose JA, Dangas G. Unstable angina: current concepts of pathogenesis and treatment. Arch Intern Med. 2000 Jan 10; 160(1):25-37.
      View in: PubMed
    313. Gruberg L, Mehran R, Dangas G, Hong MK, Mintz GS, Kornowski R, Lansky AJ, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB. Effect of plaque debulking and stenting on short- and long-term outcomes after revascularization of chronic total occlusions. J Am Coll Cardiol. 2000 Jan; 35(1):151-6.
      View in: PubMed
    314. Kini A, Marmur JD, Dangas G, Choudhary S, Sharma SK. Angiographic patterns of in-stent restenosis and implications on subsequent revascularization. Catheter Cardiovasc Interv. 2000 Jan; 49(1):23-9.
      View in: PubMed
    315. Gruberg L, Hong MK, Mehran R, Mintz GS, Kornowski R, Lansky AJ, Kent KM, Pichard AD, Satler LF, Dangas G, Wu H, Stone GW, Leon MB. In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site. Am J Cardiol. 1999 Dec 15; 84(12):1381-4.
      View in: PubMed
    316. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Kent KM, Satler LF, Stone GW, Leon MB. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation. 1999 Dec 14; 100(24):2400-5.
      View in: PubMed
    317. Laird JR, Dangas G, Jaff M, Satler LF, Mehran R, Leon MB. Intra-arterial reteplase for the treatment of acute limb ischemia. J Invasive Cardiol. 1999 Dec; 11(12):757-62.
      View in: PubMed
    318. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999 Nov 2; 100(18):1872-8.
      View in: PubMed
    319. Gruberg L, Dangas G, Leon MB. Coronary artery stents: appropriate use of adjunctive pharmacotherapy to prevent stent thrombosis. Drugs Aging. 1999 Nov; 15(5):341-8.
      View in: PubMed
    320. Kini A, Kini S, Marmur JD, Bertea T, Dangas G, Cocke TP, Sharma SK. Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices. Catheter Cardiovasc Interv. 1999 Oct; 48(2):123-9.
      View in: PubMed
    321. Dangas G, Smith DA, Badimon JJ, Unger AH, Shao JH, Meraj P, Cohen AM, Levine D, Fallon JT, Ambrose JA. Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatin. Am J Cardiol. 1999 Sep 15; 84(6):639-43.
      View in: PubMed
    322. Kini A, Marmur JD, Kini S, Dangas G, Cocke TP, Wallenstein S, Brown E, Ambrose JA, Sharma SK. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention. J Am Coll Cardiol. 1999 Sep; 34(3):663-71.
      View in: PubMed
    323. Peterson MA, Monsein LH, Dangas G, Mehran R, Leon MB. Percutaneous transcatheter management of giant coronary aneurysms. Circulation. 1999 Jul 6; 100(1):E8-E11.
      View in: PubMed
    324. Dangas G, Colombo A. Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization. Am Heart J. 1999 Jul; 138(1 Pt 2):S16-23.
      View in: PubMed
    325. Dangas G, Marmur JD, King TE, De Leon J, Sharma SK, Vidhun R, Feldman D, Stoynov MY, Badimon JJ, Ambrose JA. Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention. Am Heart J. 1999 Jul; 138(1 Pt 1):49-54.
      View in: PubMed
    326. Dangas G, Mintz GS, Mehran R, Lansky AJ, Kornowski R, Pichard AD, Satler LF, Kent KM, Stone GW, Leon MB. Preintervention arterial remodeling as an independent predictor of target-lesion revascularization after nonstent coronary intervention: an analysis of 777 lesions with intravascular ultrasound imaging. Circulation. 1999 Jun 22; 99(24):3149-54.
      View in: PubMed
    327. Dangas G, Ambrose JA, Sharma SK, Shao JH, Feldman D, Cohen AM, Marmur JD, Cocke TP, Duvvuri S, Goldman ME. The effect of early postinfarction revascularization of asymptomatic patients on left ventricular remodeling. Coron Artery Dis. 1999 Jun; 10(4):203-10.
      View in: PubMed
    328. Dangas G, Dailey-Sterling FG, Sharma SK, Chockalingham S, Albanese JR, Reich DL, Meller J, Fallon JT. Non-Q-wave infarction and ostial left coronary obstruction due to giant Lambl's excrescences of the aortic valve. Circulation. 1999 Apr 13; 99(14):1919-21.
      View in: PubMed
    329. Dangas G, Badimon JJ, Smith DA, Unger AH, Levine D, Shao JH, Meraj P, Fier C, Fallon JT, Ambrose JA. Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. J Am Coll Cardiol. 1999 Apr; 33(5):1294-304.
      View in: PubMed
    330. Kini A, Marmur JD, Duvvuri S, Dangas G, Choudhary S, Sharma SK. Rotational atherectomy: improved procedural outcome with evolution of technique and equipment. Single-center results of first 1,000 patients. Catheter Cardiovasc Interv. 1999 Mar; 46(3):305-11.
      View in: PubMed
    331. Dangas G, Stone GW. Primary mechanical reperfusion in acute myocardial infarction: the United States experience. Semin Interv Cardiol. 1999 Mar; 4(1):21-33.
      View in: PubMed
    332. Dangas G, Ambrose JA, D'Agate DJ, Shao JH, Chockalingham S, Levine D, Smith DA. Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease. Am J Cardiol. 1999 Feb 15; 83(4):583-5, A7.
      View in: PubMed
    333. Dangas G, Fuster V. The role of platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization procedures. Rev Port Cardiol. 1999 Feb; 18 Suppl 1:I49-53.
      View in: PubMed
    334. Dangas G, Khan S, Curry BH, Kini AS, Sharma SK. Angina pectoris in severe aortic stenosis. Cardiology. 1999; 92(1):1-3.
      View in: PubMed
    335. Dangas G, Mehran R, Harpel PC, Sharma SK, Marcovina SM, Dube G, Ambrose JA, Fallon JT. Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. J Am Coll Cardiol. 1998 Dec; 32(7):2035-42.
      View in: PubMed
    336. Sharma SK, Duvvuri S, Dangas G, Kini A, Vidhun R, Venu K, Ambrose JA, Marmur JD. Rotational atherectomy for in-stent restenosis: acute and long-term results of the first 100 cases. J Am Coll Cardiol. 1998 Nov; 32(5):1358-65.
      View in: PubMed
    337. Dangas G, Badimon JJ, Coller BS, Fallon JT, Sharma SK, Hayes RM, Meraj P, Ambrose JA, Marmur JD. Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab. Arterioscler Thromb Vasc Biol. 1998 Aug; 18(8):1342-9.
      View in: PubMed
    338. Dangas G, Fier C, Ambrose JA. Thrombolytic therapy in acute myocardial infarction. Drugs Today (Barc). 1998 Aug; 34(8):727-36.
      View in: PubMed
    339. Murkofsky RL, Dangas G, Diamond JA, Mehta D, Schaffer A, Ambrose JA. A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction [see comment]. J Am Coll Cardiol. 1998 Aug; 32(2):476-82.
      View in: PubMed
    340. Dangas G, Mehran R, Duvvuri S, Vidhun R, Ambrose JA, Sharma SK. Directional coronary atherectomy in acute myocardial infarction. Cardiology. 1998 Jul; 90(1):63-6.
      View in: PubMed
    341. Dangas G, Peters-Veluthamaningal C, Cocke TP, Vidhun R, Duvvuri S, Marmur JD, Sharma SK. Histopathological correlates of early arterial recoil following directional coronary atherectomy. Cardiology. 1998 Jul; 90(1):32-6.
      View in: PubMed
    342. Sharma SK, Dangas G, Mehran R, Duvvuri S, Kini A, Cocke TP, Kakarala V, Cohen AM, Marmur JD, Ambrose JA. Risk factors for the development of slow flow during rotational coronary atherectomy. Am J Cardiol. 1997 Jul 15; 80(2):219-22.
      View in: PubMed
    343. Sharma SK, Dangas G, Israel D, Collins J, Felten WR, Fattal PG, Cocke TP, Ambrose JA, Cannon L. Prospective evaluation of a stiff shaft glide wire compared with the standard straight wire in crossing severely stenotic aortic valves. Am J Cardiol. 1997 Jul 1; 80(1):103-5.
      View in: PubMed
    344. Dangas G, Gorlin R. Changing concepts in the determination of valvular stenosis. Prog Cardiovasc Dis. 1997 Jul-Aug; 40(1):55-64.
      View in: PubMed
    345. Duvvuri S, Bhalla N, Shehadeh A, Albanese JR, Dangas G, Sharma SK. A single-step stent delivery, deployment, and expansion system. Cathet Cardiovasc Diagn. 1997 Mar; 40(3):308-10.
      View in: PubMed
    346. Ambrose JA, Almeida OD, Sharma SK, Dangas G, Ratner DE. Angiographic evolution of intracoronary thrombus and dissection following percutaneous transluminal coronary angioplasty (the Thrombolysis and Angioplasty in Unstable Angina [TAUSA] trial). Am J Cardiol. 1997 Mar 1; 79(5):559-63.
      View in: PubMed
    347. Dangas G, Mehran R, Wallenstein S, Courcoutsakis NA, Kakarala V, Hollywood J, Ambrose JA. Correlation of angiographic morphology and clinical presentation in unstable angina. J Am Coll Cardiol. 1997 Mar 1; 29(3):519-25.
      View in: PubMed
    348. Dangas G, Mehran R, Duvvuri S, Ambrose JA, Sharma SK. Use of a pneumatic compression system (FemoStop) as a treatment option for femoral artery pseudoaneurysms after percutaneous cardiac procedures. Cathet Cardiovasc Diagn. 1996 Oct; 39(2):138-42.
      View in: PubMed
    349. Dangas G, Fuster V. Management of restenosis after coronary intervention. Am Heart J. 1996 Aug; 132(2 Pt 1):428-36.
      View in: PubMed
    Dangas's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067